dc.contributor |
University of Aberdeen.Other Applied Health Sciences |
|
dc.creator |
Solheim, Tora S |
|
dc.creator |
Laird, Barry J. A. |
|
dc.creator |
Balstad, Trude Rakel |
|
dc.creator |
Stene, Guro B. |
|
dc.creator |
Bye, Asta |
|
dc.creator |
Johns, Neil |
|
dc.creator |
Pettersen, Caroline H |
|
dc.creator |
Fallon, Marie |
|
dc.creator |
Fayers, Peter |
|
dc.creator |
Fearon, Kenneth C H |
|
dc.creator |
Kaasa, Stein |
|
dc.date |
2018-09-28T10:50:06Z |
|
dc.date |
2018-09-28T10:50:06Z |
|
dc.date |
2017-10 |
|
dc.date.accessioned |
2022-05-24T06:09:33Z |
|
dc.date.available |
2022-05-24T06:09:33Z |
|
dc.identifier |
Solheim , T S , Laird , B J A , Balstad , T R , Stene , G B , Bye , A , Johns , N , Pettersen , C H , Fallon , M , Fayers , P , Fearon , K C H & Kaasa , S 2017 , ' A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer ' , Journal of Cachexia, Sarcopenia and Muscle , vol. 8 , no. 5 , pp. 778-788 . https://doi.org/10.1002/jcsm.12201 |
|
dc.identifier |
2190-6009 |
|
dc.identifier |
PURE: 139437823 |
|
dc.identifier |
PURE UUID: 9f6d7a6a-5446-42d5-86bd-4ba1300b4391 |
|
dc.identifier |
Scopus: 85020711577 |
|
dc.identifier |
http://hdl.handle.net/2164/11189 |
|
dc.identifier |
https://doi.org/10.1002/jcsm.12201 |
|
dc.identifier |
8 |
|
dc.identifier |
5 |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/117845 |
|
dc.description |
Peer reviewed |
|
dc.description |
Publisher PDF |
|
dc.format |
11 |
|
dc.format |
application/pdf |
|
dc.language |
eng |
|
dc.relation |
Journal of Cachexia, Sarcopenia and Muscle |
|
dc.rights |
© 2017 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. https://creativecommons.org/licenses/by-nc-nd/4.0/ |
|
dc.subject |
SDG 3 - Good Health and Well-being |
|
dc.subject |
cachexia |
|
dc.subject |
cancer |
|
dc.subject |
randomised |
|
dc.subject |
multi-modal |
|
dc.subject |
trial |
|
dc.subject |
anti-inflammatory |
|
dc.subject |
R Medicine |
|
dc.subject |
R |
|
dc.title |
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer |
|
dc.type |
Journal article |
|